Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (441-450 of 522) with videos related to

Pageof 53
Sort By:
European Urology|February 14, 2018
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesMatthew R Cooperberg, James D Brooks, Anna V Faino, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
Urology|July 25, 2016
An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary CareE David Crawford, Matt T Rosenberg, Alan W Partin, et al.
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
Cancer Causes & Control : CCC|January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trialWilliam A Pace, Adam Olshen, Ye Wang, et al.
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
The Journal of Urology|December 3, 2014
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH databaseKatharine N Sourbeer, Lauren E Howard, Daniel M Moreira, et al.
Pageof 53

Showing results (441-450 of 522) with videos related to

Sort By:
Pageof 53
European Urology|February 14, 2018
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesMatthew R Cooperberg, James D Brooks, Anna V Faino, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
Urology|July 25, 2016
An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary CareE David Crawford, Matt T Rosenberg, Alan W Partin, et al.
European Urology|May 21, 2018
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsDonna P Ankerst, Johanna Straubinger, Katharina Selig, et al.
Cancer Causes & Control : CCC|January 17, 2026
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trialWilliam A Pace, Adam Olshen, Ye Wang, et al.
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
The Journal of Urology|December 3, 2014
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH databaseKatharine N Sourbeer, Lauren E Howard, Daniel M Moreira, et al.
Pageof 53